Literature DB >> 20876173

Day care increases the risk of respiratory morbidity in chronic lung disease of prematurity.

Sharon A McGrath-Morrow1, Grace Lee, Beth H Stewart, Brian M McGinley, Maureen A Lefton-Greif, Sande O Okelo, J Michael Collaco.   

Abstract

OBJECTIVES: Infants and children with chronic lung disease of prematurity (CLDP) are at increased risk for morbidity and mortality from respiratory viral infections. Exposure to respiratory viruses may be increased in the day care environment. The risk of respiratory morbidity from day care attendance in the CLDP population is unknown. We therefore sought to determine if day care attendance is a significant risk factor for increased respiratory morbidity and symptoms in infants and children with CLDP.
METHODS: Between January 2008 and October 2009, parents of infants and children with CLDP were surveyed. Information on perinatal history, sociodemographic information, day care attendance, and indicators of respiratory morbidity, including emergency department (ED) visits, hospitalizations, systemic corticosteroid use, antibiotic use, and respiratory symptoms, was collected on children<3 years of age. Logistic regression models were constructed to examine associations between exposure to day care and respiratory morbidities.
RESULTS: Data were collected from 111 patients with CLDP. The average gestational age was 26.2±2.0 weeks. Day care attendance was associated with significantly higher adjusted odds for ED visits (odds ratio [OR]: 3.74 [95% confidence interval (CI): 1.41-9.91]; P<.008), systemic corticosteroid use (OR: 2.22 [CI: 1.10-4.49]; P<.026), antibiotic use (OR: 2.40 [CI: 1.08-5.30]; P<.031), and days with trouble breathing (OR: 2.72 [CI: 1.30-5.69]; P<.008). Although there was an increased OR for hospitalization (OR: 3.22 [CI: 0.97-10.72]; P<.057), this did not reach statistical significance.
CONCLUSIONS: We found that day care attendance is associated with increased respiratory morbidities in young children with CLDP. Physicians should consider screening for and educating caregivers about the risks of day care attendance by young children with CLDP.

Entities:  

Mesh:

Year:  2010        PMID: 20876173     DOI: 10.1542/peds.2010-0844

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Secondhand smoke exposure in preterm infants with bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Angela D Aherrera; Timothy Ryan; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2013-06-27

2.  Interdisciplinary Care of Children with Severe Bronchopulmonary Dysplasia.

Authors:  Steven H Abman; Joseph M Collaco; Edward G Shepherd; Martin Keszler; Milenka Cuevas-Guaman; Stephen E Welty; William E Truog; Sharon A McGrath-Morrow; Paul E Moore; Lawrence M Rhein; Haresh Kirpalani; Huayan Zhang; Linda L Gratny; Susan K Lynch; Jennifer Curtiss; Barbara S Stonestreet; Robin L McKinney; Kevin C Dysart; Jason Gien; Christopher D Baker; Pamela K Donohue; Eric Austin; Candice Fike; Leif D Nelin
Journal:  J Pediatr       Date:  2016-11-28       Impact factor: 4.406

3.  Respiratory syncytial virus and seasonal influenza cause similar illnesses in children with sickle cell disease.

Authors:  Sara Christina Sadreameli; Megan E Reller; David G Bundy; James F Casella; John J Strouse
Journal:  Pediatr Blood Cancer       Date:  2014-01-31       Impact factor: 3.167

4.  Characteristics of Children with Bronchopulmonary Dysplasia with Prolonged and/or Later-Onset Pulmonary Hypertension.

Authors:  Brianna C Aoyama; Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  Ann Am Thorac Soc       Date:  2021-10

5.  Perinatal Inflammatory Biomarkers and Respiratory Disease in Preterm Infants.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow; Megan Griffiths; Raul Chavez-Valdez; Charlamaine Parkinson; Jie Zhu; Frances J Northington; Ernest M Graham; Allen D Everett
Journal:  J Pediatr       Date:  2022-04-20       Impact factor: 6.314

6.  Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life.

Authors:  Joseph M Collaco; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2021-03-17

7.  Insurance coverage and respiratory morbidities in bronchopulmonary dysplasia.

Authors:  Joseph M Collaco; Michael C Tracy; Catherine A Sheils; Jessica L Rice; Lawrence M Rhein; Leif D Nelin; Paul E Moore; Winston M Manimtim; Jonathan C Levin; Khanh Lai; Lystra P Hayden; Julie L Fierro; Eric D Austin; Stamatia Alexiou; Amit Agarwal; Natalie Villafranco; Roopa Siddaiah; Antonia P Popova; Ioana A Cristea; Christopher D Baker; Manvi Bansal; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2022-04-26

Review 8.  Bronchopulmonary dysplasia: what are its links to COPD?

Authors:  Sharon A McGrath-Morrow; Joseph M Collaco
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

Review 9.  Influences of environmental exposures on preterm lung disease.

Authors:  Joseph M Collaco; Brianna C Aoyama; Jessica L Rice; Sharon A McGrath-Morrow
Journal:  Expert Rev Respir Med       Date:  2021-06-17       Impact factor: 3.772

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.